growth/size/body
• mice appear normal at weaning but fail to gain weight
|
hematopoietic system
• increase in levels of circulating neutrophils
|
• increase in levels of circulating lymphocytes
|
• increase in circulating activated CD8+ T cells
|
• increase in levels of circulating monocytes
|
• spleens show increased expression of interfron signature genes such as Ddx58 and Isg95
|
• IgG deposition in the glomeruli of kidneys
|
• macrophages exhibit an acute elevation of proinflammatory cytokines IL-1beta, IL-6, and IP-10, but not IL-10, in response to ingesting dying cells that is not seen in control macrophages
• however, neither bone marrow-derived macrophages nor peritoneal exudate macrophages from 52 week old mice show any defects in the engulfment of dying cells in vitro indicating normal phagocytic capacity
|
homeostasis/metabolism
• levels of CXCL1, CCL4 and CCL2 are increased in 52-week old mice
|
• in 52-week old mice
|
• in 52-week old mice
|
• in 52-week old mice
|
• in 52-week old mice
|
immune system
• increase in levels of circulating neutrophils
|
• increase in levels of circulating lymphocytes
|
• increase in circulating activated CD8+ T cells
|
• increase in levels of circulating monocytes
|
• spleens show increased expression of interfron signature genes such as Ddx58 and Isg95
|
• IgG deposition in the glomeruli of kidneys
|
• macrophages exhibit an acute elevation of proinflammatory cytokines IL-1beta, IL-6, and IP-10, but not IL-10, in response to ingesting dying cells that is not seen in control macrophages
• however, neither bone marrow-derived macrophages nor peritoneal exudate macrophages from 52 week old mice show any defects in the engulfment of dying cells in vitro indicating normal phagocytic capacity
|
• levels of CXCL1, CCL4 and CCL2 are increased in 52-week old mice
|
• in 52-week old mice
|
• in 52-week old mice
|
• in 52-week old mice
|
• in 52-week old mice
|
• mice develop a systemic lupus erythematosus-like disease (SLE)
• repeated injection of dying UV-irradiated thymocytes in mice accelerates the development of SLE-like disease, including increased serum levels of autoantibodies, glomerular immune complex deposition, and increased levels of alanine aminotransferase indicative of tissue damage
|
• increase in serum levels of a broad array of antibodies against autoantigens commonly associated with SLE
|
• increase in serum levels of anti-nuclear antibodies
• mice injected with UV-irradiated thymocytes beginning at 6 weeks of age over an 8 week period show a significant increase in serum levels of ANA and anti-dsDNA antibodies compared to wild-type mice which show minimal increases
|
• increase in serum levels of anti-double-stranded DNA antibodies
• mice injected with UV-irradiated thymocytes beginning at 6 weeks of age over an 8 week period show a significant increase in serum levels of ANA and anti-dsDNA antibodies compared to wild-type mice which show minimal increases
|
• kidneys from aged mice show endocapillary proliferative glomerulonephritis
|
renal/urinary system
• mice show indications of kidney damage and show increased functional markers of kidney injury
|
• IgG and complement C1q deposition in the glomeruli of kidneys
|
• kidneys from aged mice show endocapillary proliferative glomerulonephritis
|
Mouse Models of Human Disease |
DO ID | OMIM ID(s) | Ref(s) | |
systemic lupus erythematosus | DOID:9074 |
OMIM:152700 OMIM:300809 OMIM:605480 OMIM:608437 OMIM:609903 OMIM:609939 OMIM:610065 OMIM:610066 OMIM:612254 OMIM:612378 OMIM:613145 OMIM:614420 |
J:235399 |